Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer
Phase 1
Withdrawn
- Conditions
- Non-small-cell Lung CarcinomaLung CancerNSCLCNon-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2013-02-26
- Last Posted Date
- 2014-11-17
- Lead Sponsor
- Eckhard Podack
- Registration Number
- NCT01799161
News
No news found